Lumexa Imaging Holdings, Inc. Common Stock (LMRI) fair value: what the stock is really worth
As of Sep 23, 2026: fair value of Lumexa Imaging Holdings, Inc. Common Stock $2.58, price $10.14, upside -74.6%, quality 47 out of 100. Calculated from audited financials with 26 valuation models and 37 quality factors, updated daily.
Watch Lumexa Imaging Holdings, Inc. Common Stock for free, get notified when fair value or trend changes. Plus fair value for all 35,000+ stocks, 14 days of Pro free, no card.Watch for freePro now: $1 first month
69 individual criteria per stock, every one traceableSee the method →
Price vs Fair Value
White line = price, green steps = our fair value per fiscal year. As of Sep 23, 2026.
How to read this chart
9‑month range $6.77 – $18.53 · the $10.14 price screens above the $2.58 fair value. As of Sep 23, 2026.
Follow Lumexa Imaging Holdings, Inc. Common Stock in your weekly email
Every Wednesday you see whether Lumexa Imaging Holdings, Inc. Common Stock is on track or worth a review, plus price against fair value. Free, up to 3 stocks.
We send you a confirmation link. Unsubscribe with one click.
Lumexa Imaging Holdings, Inc. owns and operates diagnostic imaging centres in the United States.
Show more
Lumexa Imaging Holdings, Inc. owns and operates diagnostic imaging centres in the United States. The company provides outpatient medical imaging services, such as magnetic resonance imaging (MRI), computed tomography (CT), and positron emission tomography (PET) services, as well as X-ray, ultrasound, and mammography diagnostic and screening imaging services. Lumexa Imaging Holdings, Inc. was founded in 2018 and is based in Raleigh, North Carolina.
Stock analysis
Lumexa Imaging Holdings, Inc. Common Stock (LMRI) currently trades at $10.14, while our model-based Fair Value estimate is $2.58, implying the stock looks roughly 293.1% overvalued today.
Show more
Valuation
How firm this estimate is: it rests on 5 models at a data quality of 87/100, which puts the evidence level at low.
Quality & growth
The Quality Score stands at 47/100 (below-average quality), in the Healthcare sector.
Expensive Growth: The company is growing, but growth may require heavy reinvestment or weak cash conversion.
Lumexa Imaging Holdings, Inc. Common Stock reported revenue of $1.0B in FY2025 versus $936M in FY2023, a compound +4.6%/yr. Reported net income was −$47.1M in FY2025.
Key figures
Market cap $904M · P/S ratio 0.88 · EPS (TTM) $−0.3900 · Net margin −4.6% · Return on equity −12.6% · Return on assets (EBIT) 2.0% · Operating margin 3.5% · Revenue (TTM) $1.0B.
Competitive moat
Our AI-assisted moat analysis scores the competitive advantage at 32 out of 100 (medium confidence).
What moves the price
For context, the median of 10 Healthcare peers we cover trades at 5% fair-value upside, at −75%, LMRI screens richer than that median.
Fair Value models
Model ⓘEach model values the company its own way (discounted cash flow, earnings, assets, dividends). The fair value above is their evidence-weighted blend, not the output of a single model.Bear ⓘBear = the cautious scenario: the same model computed with conservative anchors (lower growth, margins and valuation multiples). Together with Bull it frames a plausible valuation range, not a price target.BaseBull ⓘBull = the optimistic scenario: the same model computed with favourable anchors (higher growth, margins and valuation multiples). Together with Bear it frames a plausible valuation range, not a price target.Evidence ⓘEvidence = how well-backed THIS model's estimate is for this stock (0–100): how complete and reliable its input data are, and how well the model fits the company. The final Fair Value is an evidence-weighted blend, so better-evidenced models count more. Green ≥70, amber 50–69, grey below 50.
Growth Quality ⓘGrowth is valuable only when reinvestment earns attractive returns (Aswath Damodaran): sustainable growth depends on return on capital, reinvestment and efficiency. Basis: total company revenue over the periods shown on the cards (3Y/5Y/all years), not per share, so a merger can show up as a growth jump; per-share earnings growth is in the value-creation card.30/100
The company is growing, but growth may require heavy reinvestment or weak cash conversion.
What shareholders gained per year ⓘWe only publish this rate when it is defensible. Reason: only 3 usable fiscal years, at least 4 required
Compare Lumexa Imaging Holdings, Inc. Common Stock with another stock
Price, fair value, quality and upside side by side.
Free, no sign-up
Peer GroupⓘHow this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.Medical Devices · 358 stocks
Beats the industry median on 2/9 measures
Overall it trails its industry peers.
Valuation
Quality Score47 · Below median
Fair Value upside−75% · Bottom 25%
Profitability
Return on assets2% · Above median
Net margin (TTM)−4% · Below median
Operating margin (TTM)4% · Below median
Growth and dividend
Revenue growth3% · Below median
Balance sheet
Debt / equity1.40× · Highest 25%
Valuation Multiplesvs Medical Devices median · lower = cheaper
P/B1.54× · book value is mostly goodwill ⓘGoodwill and other intangible assets are larger than the equity. The book value mainly reflects prices paid for past acquisitions, so we do not rank this P/B against the peer group.
P/S (TTM)0.88× · Cheaper than median
EV/EBITDA19.4× · Pricier than median
Strength profile in five axes (Snowflake)
This stockSector peers
VALUE (fair-value potential)0· sector 4
FUTURE (revenue growth)16· sector 31
PAST (return on equity)0· sector 7
HEALTH (low debt)30· sector 97
DIVIDEND (yield)0· sector 38
VALUE 0: the price sits above our fair-value range.
For bloggers, editors and developers: paste this into your site or blog (a “Custom HTML” block in WordPress), it shows the current fair value and links back here. Free, plain HTML, and welcome. Full data streams (CSV/JSON) at /developers.
Cite: Fair Value Calculator (2026). "Lumexa Imaging Holdings, Inc. Common Stock Fair Value". https://www.fairvalue-calculator.com/stock/LMRI
Frequently asked questions
Is Lumexa Imaging Holdings, Inc. Common Stock (LMRI) overvalued or undervalued?
As of Sep 23, 2026, our model estimates a fair value of $2.58 versus a price of $10.14, about −75% upside (overvalued).
What is the fair value of LMRI?
Our model-based fair value for Lumexa Imaging Holdings, Inc. Common Stock is $2.58 (as of Sep 23, 2026), built from audited fundamentals. The current price: $10.14.
What is the quality score of LMRI?
Lumexa Imaging Holdings, Inc. Common Stock has a Quality Score of 47/100. It measures business quality (profitability, growth, cash flow, balance-sheet strength, investment discipline, share issuance). Market factors such as price momentum and volatility do not enter the number; they are shown separately in the detail view.
What is the price target for Lumexa Imaging Holdings, Inc. Common Stock (LMRI)?
Our model-based price target is the fair value of $2.58 (as of Sep 23, 2026) from 2 valuation models. It is a calculation from audited fundamentals, not an analyst target.
What is the Lumexa Imaging Holdings, Inc. Common Stock stock forecast for 2026?
Our models put fair value at $2.58, about −75% upside versus a price of $10.14 (overvalued). The calculation is refreshed regularly with new filings.
What is the revenue of Lumexa Imaging Holdings, Inc. Common Stock (LMRI)?
Lumexa Imaging Holdings, Inc. Common Stock reported trailing-twelve-month revenue of about $1.0B (latest available figure, as of Sep 23, 2026).
What is the intrinsic value of Lumexa Imaging Holdings, Inc. Common Stock (LMRI)?
Intrinsic value and fair value mean the same thing: what the business is worth on its numbers, independent of the share price. For Lumexa Imaging Holdings, Inc. Common Stock it is $2.58 per share (as of Sep 23, 2026), against a price of $10.14. It is the blended result of 2 valuation models (cash flow, earnings, asset, dividend).
Is Lumexa Imaging Holdings, Inc. Common Stock stock overvalued or undervalued in 2026?
As of Sep 23, 2026, LMRI trades above its calculated fair value: price $10.14, fair value $2.58, a gap of about −75% (overvalued). The calculation is refreshed with each new quarterly report, so the verdict can change during the year.
Is fair value the same as the market price of LMRI?
No. The price is what the market pays today ($10.14); the fair value is what the company's own numbers justify ($2.58). For Lumexa Imaging Holdings, Inc. Common Stock the two are $7.56 per share apart. That gap is exactly why we show both numbers side by side.
How much is Lumexa Imaging Holdings, Inc. Common Stock worth?
The market values Lumexa Imaging Holdings, Inc. Common Stock at about $904M (market capitalisation, as of Sep 23, 2026). Per share that is $10.14; our models calculate a fair value of $2.58 per share.
How solid is the balance sheet of Lumexa Imaging Holdings, Inc. Common Stock (LMRI)?
Balance-sheet figures for Lumexa Imaging Holdings, Inc. Common Stock (as of Sep 23, 2026): return on equity −12.6%, debt of 1.40 per unit of equity. They feed the Quality Score of 47/100, which measures business quality independently of the share price.
Which stocks are comparable to Lumexa Imaging Holdings, Inc. Common Stock?
From the same area (Healthcare) we also value Abbott Laboratories,, Stryker Corporation, Medtronic plc, Boston Scientific Corporation, among others. Each of them has its own fair-value calculation on this site using the same models, so the comparison is like for like.
Is Lumexa Imaging Holdings, Inc. Common Stock stock attractive at the current price?
The data as of Sep 23, 2026: price $10.14, calculated fair value $2.58 (−75%), Quality Score 47/100, from 2 models. Whether that fits your horizon and risk tolerance is your call. We provide the calculation, not investment advice.
How is the fair value of LMRI calculated?
We run Lumexa Imaging Holdings, Inc. Common Stock through 2 models from four families: discounted cash flow, earnings models, asset and balance-sheet models, and dividend models. Every model gets the same audited fundamentals; the result is the weighted average of $2.58, with the spread shown as a cautious and an optimistic scenario.
Is it still worth investing in stocks now?
The global stock market currently sits 14.1 % above its aggregate fair value. Lumexa Imaging Holdings, Inc. Common Stock itself currently trades above fair value. An expensive market is no reason to stay out and no reason to buy everything at once: keep a broad savings plan running, buy single stocks only with money you can do without, and hold part of your money liquid while the market is high. The full picture including sectors is on is it worth investing now.
What is the share price of Lumexa Imaging Holdings, Inc. Common Stock (LMRI)?
The closing price on Sep 23, 2026 was $10.14. Our model-based fair value is $2.58, about −75% upside (overvalued). We carry closing prices from our data provider, not a live tick.
What should I pay attention to with Lumexa Imaging Holdings, Inc. Common Stock right now?
The large gap to fair value rests on thin data (low evidence): fewer applicable models and a shorter history. Read it with extra caution. Solid but not exceptional quality (47/100) and above fair value, neither a clear bargain nor a standout compounder.
Key figures of Lumexa Imaging Holdings, Inc. Common Stock
How large is the market capitalisation of Lumexa Imaging Holdings, Inc. Common Stock (LMRI)?
The market capitalisation of Lumexa Imaging Holdings, Inc. Common Stock is $904M. The stock-market value of the whole company: share price times number of shares. It is what the market asks for the entire business today.
What is the P/S ratio of Lumexa Imaging Holdings, Inc. Common Stock (LMRI)?
The price-to-sales ratio of Lumexa Imaging Holdings, Inc. Common Stock is 0.88 (last twelve months). Price to sales: market value relative to yearly revenue. Useful when profit is thin or distorted.
What are the earnings per share of Lumexa Imaging Holdings, Inc. Common Stock (LMRI)?
Earnings per share at Lumexa Imaging Holdings, Inc. Common Stock are $−0.3900. Earnings per share over the last twelve months: total profit spread across every single share.
What is the net margin of Lumexa Imaging Holdings, Inc. Common Stock (LMRI)?
The net margin of Lumexa Imaging Holdings, Inc. Common Stock is −4.6% (fiscal year 2025). How much of every unit of revenue ends up as profit. 10% means 10 cents of profit per dollar of sales.
What is the return on equity of Lumexa Imaging Holdings, Inc. Common Stock (LMRI)?
The return on equity (ROE) of Lumexa Imaging Holdings, Inc. Common Stock is −12.6% (last twelve months). Profit relative to shareholders' equity, how efficiently the company works with its owners' money.
What is the EBIT return on assets of Lumexa Imaging Holdings, Inc. Common Stock (LMRI)?
On an EBIT basis the return on assets of Lumexa Imaging Holdings, Inc. Common Stock is 2.0% (avg 3y). Operating profit (EBIT) relative to everything the company owns, as a multi-year average. It describes the business model rather than one good or bad year.
What is the operating margin of Lumexa Imaging Holdings, Inc. Common Stock (LMRI)?
The operating margin of Lumexa Imaging Holdings, Inc. Common Stock is 3.5% (last twelve months). Profit from the core business (before interest and taxes) relative to revenue.
How fast is revenue growing at Lumexa Imaging Holdings, Inc. Common Stock (LMRI)?
Revenue at Lumexa Imaging Holdings, Inc. Common Stock is growing +3.1% versus a year earlier. How much revenue grew versus a year earlier (YoY). The 3-year average next to it puts the single year in context.
How much free cash flow does Lumexa Imaging Holdings, Inc. Common Stock (LMRI) generate?
The free cash flow of Lumexa Imaging Holdings, Inc. Common Stock is −$6.4M (fiscal year 2025). The cash truly left after running and investing in the business, this is what pays dividends and buybacks.
How much net debt does Lumexa Imaging Holdings, Inc. Common Stock (LMRI) carry?
The net debt of Lumexa Imaging Holdings, Inc. Common Stock is $902M (fiscal year 2025). Debt minus cash on hand. The note shows how many years of free cash flow could in theory pay it off.
Free · no account needed
Watch Lumexa Imaging Holdings, Inc. Common Stock in the live analysis
One click puts Lumexa Imaging Holdings, Inc. Common Stock on your watchlist: fair value and trend at a glance, plus comparison, the diversification check and the 35,000+ stock screener. You can also try 14 days of Pro there, no card.
Thin data
Sep 23, 2026